HIV-1 p6-Another viral interaction partner to the host cellular protein cyclophilin A

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1824, Issue 4, 2012, Pages 667-678

  Solbak, Sara M O ^a   Reksten, Tove R ^a,b   Röder, Rene ^c   Wray, Victor ^b   Horvli, Ole ^a   Raae, Arnt J ^a   Henklein, Petra ^c   Henklein, Peter ^c   Fossen, Torgils ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biacore; Cyclophilin A; HIV 1 p6; NMR; Peptidyl prolyl isomerase; SPR

Indexed keywords

CIS TRANS ISOMERASE; CYCLOPHILIN A; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; PROLINE; PROTEIN P6; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CIS TRANS ISOMERISM; ENZYME SUBSTRATE COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CYCLOPHILIN A; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ISOMERISM; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, SECONDARY; SOLVENTS; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84857470040     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2012.02.002     Document Type: Article

References (49)

1. X.F. Yu, Z. Matsuda, Q.C. Yu, T.H. Lee, and M. Essex Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation J. Gen. Virol. 76 1995 3171 3179
2. D.G. Demirov, J.M. Orenstein, and E.O. Freed The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner J. Virol. 76 2002 105 117
3. Y. Jenkins, O. Pornillos, R.L. Rich, D.G. Myszka, W.I. Sundquist, and M.H. Malim Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6Gag J. Virol. 75 2001 10537 10542
4. E. Kondo, F. Mammano, E.A. Cohen, and H.G. Gottlinger The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles J. Virol. 69 1995 2759 2764
5. Y.L. Lu, P. Spearman, and L. Ratner Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions J. Virol. 67 1993 6542 6550
6. W. Paxton, R.I. Connor, and N.R. Landau Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis J. Virol. 67 1993 7229 7237
7. J. Votteler, L. Neumann, S. Hahn, F. Hahn, P. Rauch, K. Schmidt, N. Studtrucker, S.M.O. Solbak, T. Fossen, P. Henklein, D.E. Ott, G. Holland, N. Bannert, and U. Schubert Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly Retrovirology 8 2011
8. S. Hahn, C. Setz, J. Wild, and U. Schubert The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 gag regulates its ubiquitination and MHC class I antigen presentation J. Immunol. 186 2011 5706 5718
9. T. Fossen, V. Wray, K. Bruns, J. Rachmat, P. Henklein, U. Tessmer, A. Maczurek, P. Klinger, and U. Schubert Solution structure of the human immunodeficiency virus type 1 p6 protein J. Biol. Chem. 280 2005 42515 42527
10. A. Schlessinger, J.F. Liu, and B. Rost Natively unstructured loops differ from other loops PLoS Comput. Biol. 3 2007 1335 1346
11. P. Wang, and J. Heitman The cyclophilins Genome Biol. 6 2005
12. A. Billich, F. Hammerschmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, and B. Rosenwirth Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporine A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions J. Virol. 69 1995 2451 2461
13. T. Dorfman, A. Weimann, A. Borsetti, C.T. Walsh, and H.G. Gottlinger Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions J. Virol. 71 1997 7110 7113
14. E.K. Franke, and J. Luban Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction Virology 222 1996 279 282
15. B. Rosenwirth, A. Billich, R. Datema, P. Donatsch, F. Hammerschmid, R. Harrison, P. Hiestand, H. Jaksche, P. Mayer, P. Peichl, V. Quesniaux, F. Schatz, H.J. Schuurman, R. Traber, R. Wenger, B. Wolff, G. Zenke, and M. Zurini Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppresive cyclosporine analog Antimicrob. Agents Chemother. 38 1994 1763 1772
16. M. Thali, A. Bukovsky, E. Kondo, B. Rosenwirth, C.T. Walsh, J. Sodroski, and H.G. Gottlinger Functional association of cyclophilin A with HIV-1 virions Nature 372 1994 363 365
17. J. Votteler, V. Wray, and U. Schubert Role of cyclophilin a in HIV replication, Future Virology 2 2007 65 78
18. O. Ardon, E.S. Zimmerman, J.L. Andersen, J.L. DeHart, J. Blackett, and V. Planelles Induction of G(2) arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr J. Virol. 80 2006 3694 3700
19. S.M. Solbak, T.R. Reksten, V. Wray, K. Bruns, O. Horvli, A.J. Raae, P. Henklein, R. Roder, D. Mitzner, U. Schubert, and T. Fossen The intriguing Cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding BMC Struct. Biol. 10 2010
20. K. Zander, M.P. Sherman, U. Tessmer, K. Bruns, V. Wray, A.T. Prechtel, E. Schubert, P. Henklein, J. Luban, J. Neidleman, W.C. Greene, and U. Schubert Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression J. Biol. Chem. 278 2003 43202 43213
21. D.A. Bosco, E.Z. Eisenmesser, S. Pochapsky, W.I. Sundquist, and D. Kern Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A Proc. Natl. Acad. Sci. U. S. A. 99 2002 5247 5252
22. D.A. Bosco, and D. Kern Catalysis and binding of cyclophilin a with different HIV-1 capsid constructs Biochemistry 43 2004 6110 6119
23. H.G. Gottlinger, T. Dorfman, J.G. Sodroski, and W.A. Haseltine Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release Proc. Natl. Acad. Sci. U. S. A. 88 1991 3195 3199
24. J. Martin-Serrano, T. Zang, and P.D. Bieniasz HIV-I and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress Nat. Med. 7 2001 1313 1319
25. E.L. Myers, and J.F. Allen Tsg101, an inactive homologue of ubiquitin ligase E2, interacts specifically with human immunodeficiency virus type 2 Gag polyprotein and results in increased levels of ubiquitinated Gag J. Virol. 76 2002 11226 11235
26. O. Pornillos, S.L. Alam, R.L. Rich, D.G. Myszka, D.R. Davis, and W.I. Sundquist Structure and functional interactions of the Tsg101 UEV domain EMBO J. 21 2002 2397 2406
27. L. VerPlank, F. Bouamr, T.J. LaGrassa, B. Agresta, A. Kikonyogo, J. Leis, and C.A. Carter Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag) Proc. Natl. Acad. Sci. U. S. A. 98 2001 7724 7729
28. D.G. Demirov, A. Ono, J.M. Orenstein, and E.O. Freed Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function Proc. Natl. Acad. Sci. U. S. A. 99 2002 955 960
29. G.F. Salgado, R. Marquant, A. Vogel, I.D. Alves, S.E. Feller, N. Morellet, and S. Bouaziz Structural studies of HIV-1 Gag p6ct and its interaction with Vpr determined by solution nuclear magnetic resonance Biochemistry 48 2009 2355 2367
30. H. Gottlinger How HIV-1 hijacks ALIX Nat. Struct. Mol. Biol. 14 2007 254 256
31. S. Lee, A. Joshi, K. Nagashima, E.O. Freed, and J.H. Hurley Structural basis for viral late-domain binding to Alix Nat. Struct. Mol. Biol. 14 2007 194 199
32. Q. Zhai, R.D. Fisher, H.Y. Chung, D.G. Myszka, W.I. Sundquist, and C.P. Hill Structural and functional studies of ALIX interactions with YPXnL late domains of HIV-1 and EIAV Nat. Struct. Mol. Biol. 15 2008 43 49
33. V. Dussupt, M.P. Javid, G. Abou-Jaoude, J.A. Jadwin, J. de La Cruz, K. Nagashima, and F. Bouamr The nucleocapsid region of HIV-1 gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding PLoS Pathog. 5 2009
34. P. Henklein, K. Bruns, M.P. Sherman, U. Tessmer, K. Licha, J. Kopp, C.M.C. de Noronha, W.C. Greene, V. Wray, and U. Schubert Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G(2) cell cycle arrest J. Biol. Chem. 275 2000 32016 32026
35. T.L. Hwang, and A.J. Shaka Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients J. Magn. Reson. A 112 1995 275 279
36. A. Bax, and D.G. Davis MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy J. Magn. Reson. 65 1985 355 360
37. K. Bruns, T. Fossen, V. Wray, P. Henklein, U. Tessmer, and U. Schubert Structural characterization of the HIV-1 Vpr N terminus-evidence of cis/trans-proline isomerism J. Biol. Chem. 278 2003 43188 43201
38. K. Wüthrich NMR of Proteins and Nucleic Acids 1986 John Wiley and Sons, Inc. New York
39. T.D. Goddard, D.G. Kneller, SPARKY 3, University of California, San Francisco.
40. M. Keller, C. Sager, P. Dumy, M. Schutkowski, M. Fischer Gs, and Gs Mutter Enhancing the proline effect: pseudo-prolines for tailoring cis/trans isomerisation J. Am. Chem. Soc. 120 1998 2714 2720
41. C. Grathwohl, and K. Wuthrich NMR studies of the rates of proline cis-trans isomerisation in oligopeptides Biopolymers 20 1981 2623 2633
42. R.K. Harrison, and R.L. Stein Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein-evidence for the existence of a familiy of distinct enzymes Biochemistry 29 1990 3813 3816
43. D. Kern, T. Drakenberg, M. Wikstrom, S. Forsen, H. Bang, and G. Fischer The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin FEBS Lett. 323 1993 198 202
44. K. Wiegers, G. Rutter, U. Schubert, M. Grattinger, and H.G. Krausslich Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid Virology 257 1999 261 274
45. V.L. Hsu, R.E. Handschumacher, and I.M. Armitage Peptidyl-prolyl cis-trans isomerase activity of cyclophilin studied by one-dimensional 'H nuclear magnetic resonance spectroscopy J. Am. Chem. Soc. 112 1990 6745 6747
46. D. Hubner, T. Drakenberg, S. Forsen, and G. Fischer Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy FEBS Lett. 284 1991 79 81
47. D. Kern, G. Kern, G. Scherer, G. Fischer, and T. Drakenberg Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy Biochemistry 34 1995 13594 13602
48. U. Reimer, M. Drewello, M. Jakob, G. Fischer, and M. Schutkowski Conformational state of a 25-mer peptide from the cyclophilin-binding loop of the HIV type 1 capsid protein Biochem. J. 326 1997 181 185
49. M.A. McCornack, L.T. Kakalis, C. Caserta, R.E. Handschumacher, and I.M. Armitage HIV protease substrate conformation: modulation by cyclophilin A FEBS Lett. 414 1997 88